Crossmark

Skin microvascular dysfunction as an early cardiovascular marker in primary hyperoxaluria type I

Crossref DOI link: https://doi.org/10.1007/s00467-018-4081-5

Published Online: 2018-10-01

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bruel, Alexandra

Bacchetta, Justine

Ginhoux, Tiphanie

Rodier-Bonifas, Christelle

Sellier-Leclerc, Anne-Laure

Fromy, Bérengère

Cochat, Pierre

Sigaudo-Roussel, Dominique

Dubourg, Laurence
License Information

Text and Data Mining valid from 2018-10-01
More Information

Article History

Received: 17 April 2018

Revised: 3 August 2018

Accepted: 3 September 2018

First Online: 1 October 2018

Compliance with ethical standards

: The Micro-Oxa study was approved by the local IRB (<i>Comité de Protection des Personnes Lyon Sud-Est II</i>, initial approval March 22, 2014, addendum approval April 29, 2015). Patients (PH1 and Cont-T) received oral and written information, and oral non-opposition consent of the patient (and parents for children) was collected.

: The authors declare no conflict of interest.